| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/28/2008 | EP1159298B1 Hiv peptides, antigens and vaccine compositions |
| 05/28/2008 | EP1148125B1 Human nucleoprotein having a ww domain and polynucleotide encoding the same |
| 05/28/2008 | EP1144662B1 Methods and means for modification of plant characteristics using the vernalization gene vrn2 |
| 05/28/2008 | EP1127120B1 Genomic and complete cdna sequences of human adipocyte-specific apm1 and biallelic markers thereof |
| 05/28/2008 | EP1084259B1 Corin, a serine protease |
| 05/28/2008 | EP1032668B1 Fibroblast growth factor-19 |
| 05/28/2008 | EP1009759B1 Carbohydrate crosslinked glycoprotein crystals |
| 05/28/2008 | EP0998567B1 Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 05/28/2008 | EP0998496B1 Isolated dendritic cell membrane protein genes |
| 05/28/2008 | EP0766825B1 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 05/28/2008 | CN101189516A Biomarker for ovarian and endometrial cancer: HEPCIDIN |
| 05/28/2008 | CN101189334A 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 05/28/2008 | CN101189266A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 05/28/2008 | CN101189265A Anti-IL2 antibodies |
| 05/28/2008 | CN101189264A M-CSF-specific monoclonal antibody and uses thereof |
| 05/28/2008 | CN101189262A Humanin receptor or humanin-like polypeptide receptor |
| 05/28/2008 | CN101189260A Novel soluble epcr protein of non-proteolytic origin and use thereof |
| 05/28/2008 | CN101189028A Identification and engineering of antibodies with variant Fc regions and methods of using the same |
| 05/28/2008 | CN101186922A Gene immunity preparation method for human I-type deoxythymidine kinase monoclonal antibody |
| 05/28/2008 | CN101186920A High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 05/28/2008 | CN101186651A Method for producing anti idiotypic antibodies |
| 05/28/2008 | CN101186650A Antibody against secreted N-terminal peptide or C-terminal peptide of GPC3 present in blood |
| 05/28/2008 | CN101186649A Human resource monoclonal antibody for anti-human P-selectin- epidermal growth factor functional region and hybridoma cell strain thereof |
| 05/28/2008 | CN101186648A Pseudomonas aeruginosa resisting Fab' fragment |
| 05/28/2008 | CN101186647A Method for preparing chicken coccidiosis high immunity yolk antibody |
| 05/28/2008 | CN101186636A Human papillomavirus shell protein L1 short peptide and application thereof |
| 05/28/2008 | CN101185754A Novel MHC II associated peptides |
| 05/28/2008 | CN100390288C Multivalent antibodies and uses therefor |
| 05/28/2008 | CN100390286C Novel enzyme gene and its expression product |
| 05/28/2008 | CN100390282C Immunocytokines with modulated selectivity |
| 05/28/2008 | CN100390279C Altered polypeptides with increased half-life |
| 05/28/2008 | CN100390195C Modulators of function of FAS receptors and other proteins |
| 05/28/2008 | CN100389826C Remedies for arthritis |
| 05/28/2008 | CN100389825C Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 05/28/2008 | CN100389820C Therapeutic agent comprising botulinum neurotoxin |
| 05/28/2008 | CA2601368A1 Monoclonal and polyclonal antibodies to equine albumin and hemoglobin and apparatus and methods using the antibodies in the identification and localization of ulcers and other digestive tract bleeding in equines |
| 05/27/2008 | US7378505 Detection, screening substrate; using enzyme activator;development of therapeytic drugs |
| 05/27/2008 | US7378504 Human monoclonal antibodies to Fc gamma receptor I (CD64) |
| 05/27/2008 | US7378503 inhibit binding of IGF-1 and IGF-II to IGF-IR so they act as antitumor by reducing tumor growth and/or prolonging the time of tumor progression; hybridoma cell lines; methods of preparing the compositions |
| 05/27/2008 | US7378502 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 05/27/2008 | US7378501 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/27/2008 | US7378494 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide |
| 05/27/2008 | US7378487 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 05/27/2008 | US7378486 PRO1482 antibodies |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378445 Treatment of prostate cancer |
| 05/27/2008 | US7378386 inhibiting viral replication or infection by contacting a composition with a virally infected cell with a cell impervious cephalin-binding ligand or proteins; treating an animal with a viral infection; hepatitis, influenza, AIDS, viral pneumonia or respiratory disease |
| 05/27/2008 | US7378275 Canine IL-13 receptor alpha-1 subunit nucleic acid molecules |
| 05/27/2008 | US7378273 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering |
| 05/27/2008 | US7378253 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 05/27/2008 | US7378247 Tumor preferential polypeptide for use in the prevention treatment and diagnosis of cell proliferative disorders |
| 05/27/2008 | US7378094 Antibody complex comprising monoclonal antibody that specifically binds to complement receptor 2 linked to a second antibody that binds target antigen; anticarcinogenic agents, vaccines |
| 05/27/2008 | US7378093 Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes |
| 05/27/2008 | US7378092 Immunogenic compositions for induction of anti-tumor immunity |
| 05/27/2008 | US7378091 Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| 05/27/2008 | US7378089 Supplying suppressive genetic engineered cells; antiinflammatory agents |
| 05/27/2008 | US7378080 Detection, measurement, calibration gene expression |
| 05/27/2008 | CA2322616C A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 05/27/2008 | CA2258494C Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 05/22/2008 | WO2008061020A2 Methods of treating, diagnosing or detecting cancer |
| 05/22/2008 | WO2008061013A2 Antibody-based diagnostics and therapeutics |
| 05/22/2008 | WO2008060814A2 ANTI-IL-13Rα1 ANTIBODIES AND THEIR USES THEREOF |
| 05/22/2008 | WO2008060813A2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 05/22/2008 | WO2008060791A2 Modulators of protein phosphatase 2a |
| 05/22/2008 | WO2008060780A2 Glycerol linked pegylated sugars and glycopeptides |
| 05/22/2008 | WO2008060705A2 Anti-dll4 antibodies and methods using same |
| 05/22/2008 | WO2008060645A2 Combinatorial therapy involving alpha5beta1 antagonists |
| 05/22/2008 | WO2008060617A2 Therapeutic uses of tim-3 modulators |
| 05/22/2008 | WO2008060371A1 USE OF TGF-β ANTAGONISTS TO TREAT INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |
| 05/22/2008 | WO2008060367A2 Human antibodies that bind cxcr4 and uses thereof |
| 05/22/2008 | WO2008060364A2 Humani zed antibody against amyloid beta |
| 05/22/2008 | WO2008060331A2 Antibodies to sars coronavirus |
| 05/22/2008 | WO2008059959A1 Nerve elongation promoter and elongation inhibitor |
| 05/22/2008 | WO2008059837A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 05/22/2008 | WO2008059616A1 Antibody recognizing c-domain of midkine |
| 05/22/2008 | WO2008058922A1 Marker specific to an oxidation degradation of tissues containing type iii collagen, means and methods, and kits for the tracking diagnosis or prognosis of pathologies targeted by said marker |
| 05/22/2008 | WO2008058736A1 Lingo binding molecules and pharmaceutical use thereof |
| 05/22/2008 | WO2008058706A2 Enterococcus faecalis and/or enterococcus faecium antigen |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058342A1 Compounds, compositions and methods for controlling invertebrate pests |
| 05/22/2008 | WO2008058325A1 Immunoaffinity compositions for immunodepletion of proteins |
| 05/22/2008 | WO2007132175A3 Inhibitors of hcap18/ll-37 for use in the treatment of breast cancer |
| 05/22/2008 | WO2007126439A3 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
| 05/22/2008 | WO2007123562A3 Anthrax therapies, compositions, and methods related thereto |
| 05/22/2008 | WO2007114861A3 Il-21 receptor antagonists |
| 05/22/2008 | WO2007109747A3 Methods and compositions for antagonism of rage |
| 05/22/2008 | WO2007054090A8 Therapeutic vaccines targeting hmgb1 |
| 05/22/2008 | WO2006059913A9 Modulation of ovulation |
| 05/22/2008 | US20080120732 Method for Improved Transgene Expression |
| 05/22/2008 | US20080119641 Immunoglobulin specific to junction-enriched and -associated proteins (JEAP) for use in identifying proteins localized at cell-to-cell junctions; fluorescence-labeled protein localization |
| 05/22/2008 | US20080119636 Methods and materials for cancer treatment |
| 05/22/2008 | US20080119406 caltrin or functionally active peptide fragment together with a pharmaceutically acceptable carrier; osteroporosis, osteoarthritis, Paget's disease, osteomalacia, prolonged bed rest, chronic disuse of a limb, anorexia, microgravity, exogenous and endogenous gonadal insufficiency, bone fracture |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080119399 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 05/22/2008 | US20080119398 Modified Thioredoxin |
| 05/22/2008 | US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 05/22/2008 | US20080118967 Magnetic Enrichment Method, a Reactor Unit for Micro Particles and a Magnet Unit |
| 05/22/2008 | US20080118952 Polynucelotides encoding novel variants of the TRP channel family member, LTRPC3 |
| 05/22/2008 | US20080118951 Nogo receptor homologues and their use |